Articles from Inspection Monitor (February 1, 1996)

Title	Author	Type	Words
ANDA check hits U.K. bulk drug company.		Brief Article	826
B & L, FDA wrangle over specs for corneal shields.		Brief Article	685
Bausch & Lomb hit for stability, sterility slip-ups.		Brief Article	745
Deferral & acceptance, error reports top UBS 483.		Brief Article	661
Donor suitability, records cited at Alpha Therapeutic.		Brief Article	423
FDA checks blood bank computer validation.		Brief Article	540
FDA checks bulk firm for stability-related issues.		Brief Article	789
FDA or EPA? Cottrell argues over disinfectants, sterilants.		Brief Article	958
Inspection Log.		Brief Article	517
Inspections seen replacing ELA, other CBER rules.		Brief Article	468
Post-approval inspection of Sigmedics grows.		Brief Article	813
Sterile powder company disagrees with FDA on USP fill requirements.		Brief Article	657
Surgical gown sterilizer inspected but spared 483.		Brief Article	262